MX385726B - Procesos para la preparación de compuestos de pirimidinilciclopentano. - Google Patents

Procesos para la preparación de compuestos de pirimidinilciclopentano.

Info

Publication number
MX385726B
MX385726B MX2020009462A MX2020009462A MX385726B MX 385726 B MX385726 B MX 385726B MX 2020009462 A MX2020009462 A MX 2020009462A MX 2020009462 A MX2020009462 A MX 2020009462A MX 385726 B MX385726 B MX 385726B
Authority
MX
Mexico
Prior art keywords
preparation
processes
compounds
pyrimidinylcyclopentane
pyrimidinylcyclopentane compounds
Prior art date
Application number
MX2020009462A
Other languages
English (en)
Other versions
MX2020009462A (es
Inventor
Francis Gosselin
Hans Iding
Michelangelo Scalone
Reinhard Reents
Original Assignee
Hoffmann La Roche
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Genentech Inc filed Critical Hoffmann La Roche
Publication of MX2020009462A publication Critical patent/MX2020009462A/es
Publication of MX385726B publication Critical patent/MX385726B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/02—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from isocyanates with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención se relaciona con un proceso para la preparación de un compuesto de fórmula (I), donde R1 es como se define en la presente, que es útil como un intermediario en la preparación de los compuestos farmacéuticos activos.
MX2020009462A 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano. MX385726B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13193030 2013-11-15
PCT/US2014/065567 WO2015073739A1 (en) 2013-11-15 2014-11-13 Processes for the preparation of pyrimidinylcyclopentane compounds

Publications (2)

Publication Number Publication Date
MX2020009462A MX2020009462A (es) 2021-08-31
MX385726B true MX385726B (es) 2025-03-18

Family

ID=49582648

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2016006299A MX367620B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.
MX2019006959A MX374852B (es) 2013-11-15 2014-11-13 Procesos para la preparacion de compuestos de pirimidinilciclopentano
MX2020009462A MX385726B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2016006299A MX367620B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.
MX2019006959A MX374852B (es) 2013-11-15 2014-11-13 Procesos para la preparacion de compuestos de pirimidinilciclopentano

Country Status (21)

Country Link
US (3) US9862689B2 (es)
EP (3) EP3068770B1 (es)
JP (4) JP6374503B2 (es)
KR (2) KR102698200B1 (es)
CN (3) CN112898210B (es)
AR (1) AR098427A1 (es)
AU (5) AU2014348570B2 (es)
CA (2) CA3207199A1 (es)
ES (2) ES2765511T3 (es)
HR (2) HRP20192340T1 (es)
HU (1) HUE063095T2 (es)
IL (3) IL245636B (es)
MX (3) MX367620B (es)
MY (2) MY191759A (es)
NZ (1) NZ720805A (es)
PL (2) PL3068770T3 (es)
RU (1) RU2702355C1 (es)
SG (1) SG10201901578UA (es)
SI (1) SI3068770T1 (es)
WO (1) WO2015073739A1 (es)
ZA (2) ZA201603434B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112898210B (zh) 2013-11-15 2025-02-21 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
PL3197875T3 (pl) 2014-09-26 2020-03-31 F. Hoffmann-La Roche Ag Sposoby wytwarzania związków (cyklopentylo[d]pirymidyn-4-ylo)piperazynowych
CN109789141B (zh) 2016-08-10 2022-08-26 豪夫迈·罗氏有限公司 包含Akt蛋白激酶抑制剂的药物组合物
GB201802383D0 (en) * 2018-02-14 2018-03-28 Givaudan Sa Process

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545165B1 (en) 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
CN101180282B (zh) * 2005-05-24 2011-09-21 霍夫曼-拉罗奇有限公司 (s)-4-氟甲基-二氢-呋喃-2-酮的制备
CN101198594A (zh) * 2005-06-22 2008-06-11 尼科梅德有限责任公司 用于制备生产三环苯并咪唑类的中间体的方法
RU2481336C2 (ru) * 2006-07-06 2013-05-10 Эррэй Биофарма Инк. Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (xx) 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
JP2010536385A (ja) 2007-08-24 2010-12-02 コデクシス, インコーポレイテッド (r)−3−ヒドロキシチオランの立体選択的生成のための改善されたケトレダクターゼポリペプチド
US8835434B2 (en) * 2008-01-09 2014-09-16 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
US8853216B2 (en) * 2008-01-09 2014-10-07 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
AR070176A1 (es) * 2008-01-17 2010-03-17 Novartis Ag Procesos de sintesis de inhibidores de nep, compuestos intermediarios y uso de los mismos en la sintesis
WO2010025238A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
SI2329014T1 (sl) 2008-08-29 2015-01-30 Codexis, Inc. Polipeptidi ketoreduktaze za stereoselektivno produkcijo (4s)-3(5s)-5(4-fluorofenil)-5-hidroksipentanoil)-4-fenil-1,3-oksazolidin -2-ona
US20110054174A1 (en) * 2009-08-28 2011-03-03 Stephan Bachmann Process for the preparation of a glucokinase activator compound
KR20130058672A (ko) * 2010-04-16 2013-06-04 제넨테크, 인크. PI3K/AKT 키나제 경로 억제제 효능에 대한 예측 바이오마커로서의 FOXO3a
FI2694072T4 (fi) * 2011-04-01 2024-09-30 Genentech Inc Akt-inhibiittoriyhdisteen ja abirateronin yhdistelmä käytettäväksi terapeuttisissa hoidoissa
LT2858989T (lt) * 2012-05-17 2020-08-10 Genentech, Inc. Akt inhibuojančio pirimidinil-ciklopentano junginio amorfinė forma, jo kompozicijos ir būdai
EP2850200A1 (en) * 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
ES2588878T3 (es) 2012-05-17 2016-11-07 Array Biopharma, Inc. Proceso para preparar compuestos de ciclopentilpirimidina hidroxilada
ES2582557T3 (es) 2012-05-17 2016-09-13 Array Biopharma, Inc. Proceso para la preparación de compuestos hidroxilados de ciclopentilpirimidina
BR112014028585B1 (pt) 2012-05-17 2020-12-22 Genentech , Inc processo para fabricação de aminoácidos, e seus intermediários
CN112898210B (zh) 2013-11-15 2025-02-21 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
PL3197875T3 (pl) 2014-09-26 2020-03-31 F. Hoffmann-La Roche Ag Sposoby wytwarzania związków (cyklopentylo[d]pirymidyn-4-ylo)piperazynowych

Also Published As

Publication number Publication date
US20160297773A1 (en) 2016-10-13
NZ720805A (en) 2022-01-28
KR102493603B1 (ko) 2023-01-31
JP2016539939A (ja) 2016-12-22
US20200062717A1 (en) 2020-02-27
HRP20192340T1 (hr) 2020-04-03
AU2024205845B2 (en) 2026-08-06
CN110590606A (zh) 2019-12-20
JP6857219B2 (ja) 2021-04-14
MX2020009462A (es) 2021-08-31
BR112016011048A2 (pt) 2017-08-08
RU2016123365A (ru) 2017-12-18
SG10201901578UA (en) 2019-03-28
AU2019202461A1 (en) 2019-05-02
CA3207199A1 (en) 2015-05-21
CN112898210B (zh) 2025-02-21
HUE063095T2 (hu) 2023-12-28
ZA201603434B (en) 2020-08-26
CN112898210A (zh) 2021-06-04
EP3656764A1 (en) 2020-05-27
EP4282973A2 (en) 2023-11-29
PL3656764T3 (pl) 2024-01-22
AU2019202461B2 (en) 2021-01-14
IL245636B (en) 2019-12-31
EP4282973A3 (en) 2024-03-27
CN105899492B (zh) 2021-08-24
MX2019006959A (es) 2019-08-01
ES2765511T3 (es) 2020-06-09
CA2930870C (en) 2023-09-19
EP3068770B1 (en) 2019-10-23
JP6374503B2 (ja) 2018-08-15
CA2930870A1 (en) 2015-05-21
EP3656764C0 (en) 2023-07-05
ZA202002611B (en) 2023-10-25
AU2014348570A1 (en) 2016-06-09
MY191759A (en) 2022-07-14
RU2019130505A (ru) 2020-02-18
US10858324B2 (en) 2020-12-08
JP2021100953A (ja) 2021-07-08
IL281072A (en) 2021-04-29
KR20160075816A (ko) 2016-06-29
IL271331A (en) 2020-01-30
PL3068770T3 (pl) 2020-04-30
US9862689B2 (en) 2018-01-09
EP3656764B1 (en) 2023-07-05
JP7377828B2 (ja) 2023-11-10
AU2021202196A1 (en) 2021-05-06
JP6634428B2 (ja) 2020-01-22
BR112016011048A8 (pt) 2020-04-22
AU2024205845A1 (en) 2024-09-05
KR102698200B1 (ko) 2024-08-26
MY174153A (en) 2020-03-11
CN110590606B (zh) 2023-02-17
SI3068770T1 (sl) 2020-02-28
AU2022275477A1 (en) 2023-01-05
EP3068770A1 (en) 2016-09-21
US10435378B2 (en) 2019-10-08
US20180086722A1 (en) 2018-03-29
MX2016006299A (es) 2017-02-22
MX374852B (es) 2025-03-06
RU2702355C1 (ru) 2019-10-08
IL245636A0 (en) 2016-06-30
JP2019218384A (ja) 2019-12-26
HRP20231100T1 (hr) 2023-12-22
KR20220139440A (ko) 2022-10-14
AU2014348570B2 (en) 2019-02-28
IL271331B (en) 2021-03-25
HK1223102A1 (zh) 2017-07-21
MX367620B (es) 2019-08-28
AR098427A1 (es) 2016-05-26
IL281072B (en) 2022-05-01
CN105899492A (zh) 2016-08-24
JP2018052966A (ja) 2018-04-05
WO2015073739A1 (en) 2015-05-21
EP3068770A4 (en) 2017-04-19
ES2957314T3 (es) 2024-01-17

Similar Documents

Publication Publication Date Title
WO2014052506A3 (en) Facilitating affective feedback using wearable computing devices
WO2015108601A3 (en) Vibration energy compensation for a skin surface microphone ("ssm") in wearable communication devices
PH12015501082A1 (en) Pyridine -2-amides useful as cb2 agonists
JO3475B1 (ar) ناهضات مستقبل سوماتوستاتين نوع فرعي 4 (sstr4) جديدة
EA201590065A1 (ru) Аналоги глюкагона, проявляющие активность на рецепторе gip
PL410261A1 (pl) Urządzenie do elektroprodukcji lub elektrorafinacji materiału
MX374852B (es) Procesos para la preparacion de compuestos de pirimidinilciclopentano
EP4202959A3 (en) Overvoltage protection devices including wafer of varistor material
SMT201700235T1 (it) Schema universale adattativo ed estensibile per dispositivi internet delle cose (iot) eterogenei
BR112014016136A8 (pt) estruturas de pacote incluindo antenas distintas montadas em um dispositivo
MX384764B (es) Panel de antena.
MX352817B (es) Dispositivo sostenible con una mano para tratamiento dérmico accionado eléctricamente.
EP2634809A3 (en) Field effect transistor
EA201200728A1 (ru) Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат
EA201690478A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТРИАЗОЛ[4,5-d]ПИРИМИДИНА
WO2014195482A3 (en) Organic electronic device
IT1401748B1 (it) Transistori ad alta mobilita' elettronica con elettrodo di field plate
CA2891755C (en) Substituted pyrido-piperazinone derivatives as gamma secretase modulators
GB2490465A (en) Electrode treatment process for organic electronic devices
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора
DE102018214362B8 (de) Direkt am gerät zu montierender abschirmverbinder
MX2015011536A (es) Nuevos antagonistas de receptores trpa1 de sulfamidas.
BR112016007526A2 (pt) formulação de tratamento contra hiv de atazanavir e cobicistat
NZ711191A (en) Benzo-fused heterocyclic derivatives useful as agonists of gpr120
JP2014179314A5 (es)